CCM
AZN icon

Cullen Capital Management’s AstraZeneca AZN Stock Holding History

Cullen Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-20,770
Closed -$2.07M – 121
2019
Q4 		$2.07M Sell
20,770
-6,595
-24% -$621K 0.08% 87
2019
Q3 		$2.44M Sell
27,365
-11,860
-30% -$1.03M 0.1% 83
2019
Q2 		$3.24M Sell
39,225
-8,510
-18% -$667K 0.13% 84
2019
Q1 		$3.86M Sell
47,735
-10,818
-18% -$853K 0.15% 70
2018
Q4 		$4.45M Buy
58,553
+6,010
+11% +$469K 0.19% 64
2018
Q3 		$4.16M Sell
52,543
-743,997
-93% -$56.3M 0.15% 72
2018
Q2 		$55.9M Sell
796,540
-96,603
-11% -$6.95M 2.12% 24
2018
Q1 		$62.5M Buy
893,143
+10,900
+1% +$755K 2.21% 24
2017
Q4 		$61.2M Buy
882,243
+645
+0.1% +$43.5K 2.1% 28
2017
Q3 		$59.7M Sell
881,598
-10,835
-1% -$685K 2.08% 26
2017
Q2 		$60.8M Sell
892,433
-44,762
-5% -$2.92M 2.14% 25
2017
Q1 		$58.4M Sell
937,195
-44,863
-5% -$2.61M 2.05% 28
2016
Q4 		$53.7M Sell
982,058
-10,420
-1% -$592K 1.85% 29
2016
Q3 		$65.2M Buy
992,478
+239,845
+32% +$15.7M 2.21% 23
2016
Q2 		$45.4M Hold
752,633
– – 1.6% 27
2016
Q1 		$42.4M Sell
752,633
-40,142
-5% -$2.41M 1.5% 32
2015
Q4 		$53.8M Buy
792,775
+1,225
+0.2% +$80.3K 1.82% 29
2015
Q3 		$50.4M Buy
791,550
+34,550
+5% +$2.27M 1.77% 29
2015
Q2 		$48.2M Buy
757,000
+26,850
+4% +$1.84M 1.54% 28
2015
Q1 		$50M Sell
730,150
-20,850
-3% -$1.45M 1.4% 30
2014
Q4 		$52.9M Sell
751,000
-1,100
-0.1% -$78.8K 1.44% 30
2014
Q3 		$53.7M Sell
752,100
-22,850
-3% -$1.67M 1.47% 31
2014
Q2 		$57.6M Sell
774,950
-775,950
-50% -$56.1M 1.5% 32
2014
Q1 		$101M Buy
1,550,900
+97,500
+7% +$6.3M 2.72% 14
2013
Q4 		$86.3M Sell
1,453,400
-60,100
-4% -$3.26M 2.27% 23
2013
Q3 		$78.6M Hold
1,513,500
– – 2.23% 25
2013
Q2 		$71.6M Buy
+1,513,500
New +$77.1M 2.17% 27

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cullen Capital Management's AZN Position: Q1 2020 in Review

Cullen Capital Management sold out of AstraZeneca (AZN) in Q1 2020, closing a stake of 20,770 shares — an estimated $2.07M sold.

Cullen Capital Management first reported a position in AZN in Q2 2013 and held it in 27 quarters. The position peaked at $101M in Q1 2014. 604 funds tracked by Wall St. Rank hold AZN as of Q1 2020.

  • Cullen Capital Management reported no remaining AstraZeneca position as of Q1 2020 after selling out during the quarter.
  • Cullen Capital Management sold 20,770 AstraZeneca shares in Q1 2020, an estimated $2.07M.
  • Cullen Capital Management first reported a position in AstraZeneca in Q2 2013 and held it in 27 quarters.
  • Cullen Capital Management's AstraZeneca position peaked at $101M in Q1 2014.
  • 604 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2020.

Based on Cullen Capital Management's 13F filing for Q1 2020, filed 5 May 2020.